Phenotypic and functional characterization of T cells from patients with myasthenia gravis
- PMID: 1979338
- PMCID: PMC329850
- DOI: 10.1172/JCI114948
Phenotypic and functional characterization of T cells from patients with myasthenia gravis
Abstract
A study of cell surface phenotypes of PBL of myasthenia gravis (MG) patients showed that their T cells had a significantly higher percentage of 4B4+ T cells (the helper/inducer subset) than age- and sex-matched controls. The PBL of MG patients proliferated significantly higher than those of normal subjects (NS) in response to the purified alpha chain of the acetylcholine receptor (AChR). Anti-AChR antibody was present in sera of 88% of MG and none of the NS. The PBL B cells from MG only, when cultured with autologous T cells and stimulated with either pokeweed mitogen (69%), or AChR-alpha chain (38%), secreted antibody to AChR-alpha chain, whereas T and B cells alone secreted no antibody. T cells from PBL of MG patients were more readily cloned than T cells of NS, by limiting dilution, in the presence of recombinant IL-2 and in the absence of AChR-alpha chain. About 50% of T cell clones from MG patients, compared to none from NS, proliferated to AChR-alpha chain. This response was HLA-DR restricted. MG T cell clones did not display significant cytotoxic activity, as compared to control T cell clones. Our results indicate that in MG, 4B4+ regulatory T cells play their role in the pathogenesis of MG, not by cytotoxicity, but more likely by their ability to stimulate specific antibody production by B cells.
Similar articles
-
Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.J Lab Clin Med. 1994 Aug;124(2):231-41. J Lab Clin Med. 1994. PMID: 8051487
-
The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.Hum Antibodies. 1997;8(2):90-4. Hum Antibodies. 1997. PMID: 9289393
-
Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.J Immunol. 1985 Oct;135(4):2393-9. J Immunol. 1985. PMID: 2411794
-
On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.Crit Rev Immunol. 2001;21(1-3):1-27. Crit Rev Immunol. 2001. PMID: 11642597 Review.
-
T cell recognition of the acetylcholine receptor in myasthenia gravis.Ann N Y Acad Sci. 1998 May 13;841:283-308. doi: 10.1111/j.1749-6632.1998.tb10936.x. Ann N Y Acad Sci. 1998. PMID: 9668248 Review. No abstract available.
Cited by
-
CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis.Clin Exp Immunol. 1995 Feb;99(2):233-9. doi: 10.1111/j.1365-2249.1995.tb05538.x. Clin Exp Immunol. 1995. PMID: 7851017 Free PMC article.
-
Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression.J Neurol. 1994 Feb;241(4):218-22. doi: 10.1007/BF00863771. J Neurol. 1994. PMID: 8195820
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous